期刊文献+

肺癌与一氧化氮合酶表达关系的研究 被引量:4

暂未订购
导出
摘要 目的 研究人体肺癌组织中一氧化氮合酶各亚型的表达及其与肺癌生物学行为的关系。方法 采用免疫组织化学方法检测24例人体肺癌组织中一氧化氮合酶三种亚型的表达情况,并采用计算机自动图像分析系统对免疫组化染色强度进行测定。结果 肺癌组织中有三种亚型的一氧化氮合酶表达,以NOS1和NOS3表达为主,其中,NOS1在腺癌中的表达强于鳞癌(P<0.05),NOS1和NOS3在临床一、二期肺癌的表达高于三、四期肺癌(P<0.001),无淋巴结转移者NOS1和NOS3的表达高于淋巴结转移者(P<0.02和P<0.001)。结论 NOS尤其是NOS1和NOS3在肺癌组织中的表达可以抑制肺癌的进展。
出处 《实用肿瘤学杂志》 CAS 2000年第2期95-97,共3页 Practical Oncology Journal
  • 相关文献

参考文献9

  • 1ThomsenLL,MilesDW,HapperfieldL,etal.Nitricoxidesynthaseactivityinhumanbreastcancer.BrJCancer,1995;72:41~44
  • 2KlitzT,BlochW,VolbergC,etal.Selectiveexpressionofinduciblenitricoxidesynthaseinhumanprostatecarcinoma.Cancer,199;82(10):1897~1903
  • 3RosbeKW,PrazmaJ,PetruszP,etal.Immunohistochemicalcharacterizationofnitricoxidesynthaseactivityinsquamouscellcarcinomaoftheheadandneck.OtolaryngolHeadNeckSurg,1995;113(5):541~549
  • 4FujimotoH,AndoY,YamashitaT,etal.Nitricoxidesynthaseactivityinhumanlungcancer.JpnJCancerRes,1997;88:1190~1198
  • 5CobbsCS,BrenmanJE,AldapeKD,etal.Expressionofnitricoxidesynthaseinhumancentralnervoussystemtumors.CancerRes.1995;55(4):727~30
  • 6MitchellJB,WinkDA,GegraffW.Hypoxicmammaliancellradio-sensitisationbynitricoxide.CancerRes,1993;53:5845~5848
  • 7颜亮.一氧化氮合酶在人吞噬细胞的表达上调TNF-α生成[J].细胞与分子免疫学杂志,1997,13(1):9-12. 被引量:3
  • 8ZicheM,MorbidelliL,ChoudhuriR,etal.Nitricoxidesynthaseliesdownstreamfromvascularendothelialgrowthfactor-inducedbutnotbasicfibroblastgrowthfactor-inducedangiogenesis.JClinInvest,1997;99:2625~2634
  • 9BabaeiS,KuliszewskaKT,MongeJC,etal.Roleofnitricoxideintheangiogenicresponseinvitrotobasicfibroblastgrowthfactor.CircRes,1998;82(9):1007~1015

二级参考文献1

  • 1颜亮,J Immunol,1994年,153卷,1825页

共引文献2

同被引文献13

  • 1[1]Ziche M,Morbidel L, Choudhuri R et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor induced but not basic fibroblast growth factor induced angiogenesis[J]. J Clin Invest, 1997, 99(8):2625-2634.
  • 2[2]Babaei S,Kuliszewska KT, Monge JC et al.Role of nitric oxide in the angiogenic response in vitro to bastic fibroblast growth factor[J]. Circ Res,1998, 82(9):1007-1015.
  • 3[5]Weiderner N. Intratumor nicrovessel density as a prognostic factor in cancer [J].Am J Pathal,1995,147(1):9-19.
  • 4[6]Gendan JC, Topping KC, Pruitt J et al. Inflammatory mediators stimulate arginine transport and arginine derived nitric oxide production in a murine breast cancer cell line[J]. J Surg Res, 1996, 60(3):284-288.
  • 5[7]Fontanini G, Vignati S, Bigini D et al. Neoangiogenesis: a putative marker of malignancy in non-small-cell lung cancer(NSCLC) development[J]. Int J Cancer,1996, 67(4):615-619.
  • 6[8]Cheon KT, Choi KH, Lee HB et al. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer[J]. Lung,2000,178(6):351-360 .
  • 7[11]Liu CY, Wang CH, Chen HC et al, Increased level of exhaled nitric oxide and up-regualtion of inducible nitric oxide synthase in patients with primary lung cancer[J]. Br J Cancer,1998,78(4):534-541.
  • 8[13]Weiderner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow [J]. J Pathol,1998, 184(1):119-122.
  • 9黄克楠,冯英明.一氧化氮和肺癌[J].中国肿瘤临床与康复,2000,7(3):94-95. 被引量:5
  • 10秦艳芳,向军俭,杨红宇.碱性成纤维细胞生长因子与肿瘤[J].国外医学(肿瘤学分册),2001,28(4):256-259. 被引量:28

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部